2023. Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s188. DOI:https://doi.org/10.25251/skin.7.supp.188.